Long-term evidence found all patients treated with Evoke were “clinically significant responders in at least one outcome measure of pain relief, function, sleep, quality of life, or mood,” according to a July 19 news release. One in two Evoke patients also saw a holistic outcome response.
The Evoke system is the only smart spinal cord stimulator that senses and measures responses to stimulation, according to Saluda Medical. It can adjust therapy more than 4 million times daily for chronic pain patients.
The study, published in Pain, can be read here.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
